Diabetic Macular Edema (DME) Completed Phase 2 / 3 Trials for Triamcinolone (DB00620)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00148330Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX StudyTreatment
NCT00148265A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular OedemaTreatment
NCT00167518Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)Treatment
NCT02985619Bevacizumabe or Triamcinolone for Persistent Diabetic Macular EdemaTreatment